An acquired HER2 T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant-driven breast cancer Meeting Abstract


Authors: Hanker, A. B.; Brewer, M. R.; Sheehan, J. H.; Koch, J. P.; Lanman, R.; Hyman, D. M.; Cutler, R. E.; Lalani, A. S.; Cross, D.; Lovly, C. M.; Meiler, J.; Arteaga, C. L.
Abstract Title: An acquired HER2 T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant-driven breast cancer
Meeting Title: 2016 San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 77
Issue: 4 Suppl.
Meeting Dates: 2016 Dec 6-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2017-02-01
Language: English
ACCESSION: WOS:000397999001094
DOI: 10.1158/1538-7445.sabcs16-p3-03-03
PROVIDER: wos
Notes: Meeting Abstract: P3-03-03 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Hyman
    354 Hyman